Effect of empagliflozin on left ventricular contractility and peak oxygen uptake in subjects with type 2 diabetes without heart disease: results of the EMPA-HEART trial.

Cardiovasc Diabetol · 2022 · PMC9467417 · PMID 36096863

Europe PMC DOI

hedged sentences

0.1200

closest p · 2.4× alpha

0.1200

boldest claim

The sentences

showed a trendp = 0.12not close (p > 0.1)

Accordingly, in the present study, VO 2peak values showed a trend to be lower in those with LV-GLS below the median (17.5 ± 1.0 vs 19.9 ± 1.0 mL/min/kg, p = 0.12).

also in 53,322 other papers

of borderline significanceno p-value reported

All tests were conducted at a two-sided (and when of borderline significance also one-sided) α level of 0.05.

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.